COBALT advised Quattromed HTI Labs on purchase transaction

COBALT advised leading European laboratory services provider Synlab on a transaction involving aquisition of 100% Medicap Holding shares from Baltcap Private Equity Fund and minority shareholders.

In Estonia, Finland and Lithuania Medicap Holding Labs operate as Quattromed and Sorpo brands.

This transaction introduces Synlab to three new markets, extending its activities in Europe and making Synlab the first pan-European medical laboratory in the Baltics.

The project legal team included COBALT partners Karina Paatsi and Peeter Kutman and Senior Associates Heili Haabu, Liina Jents, Triin Ploomipuu and Maria Peterson.